0.5924
price down icon4.85%   -0.0302
after-market Dopo l'orario di chiusura: .59 -0.0024 -0.41%
loading
Precedente Chiudi:
$0.6226
Aprire:
$0.6189
Volume 24 ore:
1.40M
Relative Volume:
0.43
Capitalizzazione di mercato:
$95.86M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
14.81
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
+0.58%
1M Prestazione:
-38.96%
6M Prestazione:
-83.86%
1 anno Prestazione:
-89.93%
Intervallo 1D:
Value
$0.5805
$0.6277
Intervallo di 1 settimana:
Value
$0.55
$0.67
Portata 52W:
Value
$0.5271
$7.105

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Nome
Ironwood Pharmaceuticals Inc
Name
Telefono
617-621-7722
Name
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Dipendente
253
Name
Cinguettio
@ironwoodpharma
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
IRWD's Discussions on Twitter

Confronta IRWD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
0.5924 95.31M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.25 49.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
165.40 71.87B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.80 4.35M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.59 44.73B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.15 18.98B 16.54B -1.64B 749.00M -1.45

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-15 Downgrade Jefferies Buy → Hold
2025-04-15 Downgrade Wells Fargo Overweight → Equal Weight
2025-04-14 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 Iniziato Leerink Partners Market Perform
2024-08-08 Downgrade CapitalOne Overweight → Equal Weight
2024-01-17 Iniziato Craig Hallum Buy
2023-12-14 Iniziato Wells Fargo Overweight
2023-11-09 Iniziato Jefferies Buy
2023-09-28 Iniziato JMP Securities Mkt Outperform
2022-09-02 Iniziato CapitalOne Overweight
2022-04-22 Iniziato Piper Sandler Overweight
2020-09-30 Downgrade Wells Fargo Overweight → Equal Weight
2020-06-17 Iniziato Northland Capital Outperform
2019-07-10 Ripresa Credit Suisse Neutral
2019-03-27 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2019-02-25 Aggiornamento H.C. Wainwright Sell → Neutral
2019-01-24 Aggiornamento JP Morgan Underweight → Neutral
2018-11-07 Downgrade Credit Suisse Outperform → Neutral
2018-11-07 Downgrade JP Morgan Neutral → Underweight
2018-07-23 Iniziato H.C. Wainwright Sell
2018-05-09 Downgrade Morgan Stanley Equal-Weight → Underweight
2018-01-05 Downgrade BofA/Merrill Buy → Underperform
2017-12-06 Downgrade Mizuho Buy → Neutral
2017-07-21 Downgrade JP Morgan Overweight → Neutral
2017-05-03 Iniziato Wells Fargo Outperform
2017-04-07 Reiterato Mizuho Buy
2017-02-22 Reiterato Barclays Equal Weight
2016-11-04 Reiterato Mizuho Buy
2016-10-24 Reiterato Wedbush Neutral
2016-10-10 Reiterato Mizuho Buy
2016-09-27 Reiterato WallachBeth Hold
Mostra tutto

Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie

pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock - Investing.com Australia

May 20, 2025
pulisher
May 19, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 19, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025
pulisher
May 10, 2025

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call - MSN

May 10, 2025
pulisher
May 09, 2025

Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price at $4.78 - Defense World

May 09, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ironwood: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook - Investing.com

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Maintains LINZESS Sales Outlook Amid Pricing Challenges | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood (IRWD) Reports Q1 Revenue Shortfall, Ending Quarter with Increased Cash Reserves | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Q1 2025 Earnings: EPS of -$0.23 Misses Estimate, Revenue Falls Short at $41.14 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 07, 2025
pulisher
May 01, 2025

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for - Yahoo

May 01, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sci - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference | IRWD Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025 - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock News - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares rise - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - ADVFN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 Guidance and Raises Adjusted EBITDA - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support - itemonline.com

Apr 22, 2025
pulisher
Apr 18, 2025

Ironwood looks for strategic options after regulatory hurdle for lead drug - MSN

Apr 18, 2025
pulisher
Apr 18, 2025

Ironwood Pharmaceuticals to Explore Strategic Alternatives to Maximize Value for Stockholders - marketscreener.com

Apr 18, 2025
pulisher
Apr 17, 2025

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Ironwood Shares Tank on Regulatory Update for Apraglutide - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Setback After FDA Request - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges A - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Jefferies Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Wells Fargo Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Ironwood's Strategy Shake-Up Raises Eyebrows As Shares Tumble - Finimize

Apr 15, 2025
pulisher
Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges (IRWD:NASDAQ) - Seeking Alpha

Apr 15, 2025
pulisher
Apr 15, 2025

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Apr 15, 2025

Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$8.59
price down icon 0.12%
drug_manufacturers_specialty_generic HCM
$13.23
price down icon 1.34%
drug_manufacturers_specialty_generic RDY
$14.56
price down icon 1.29%
$123.03
price up icon 0.32%
$315.64
price up icon 0.25%
$18.15
price up icon 2.48%
Capitalizzazione:     |  Volume (24 ore):